AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Learn why stock market indices matter for benchmark reporting, performance comparison, and portfolio context in everyday investing.
28,349 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
AI chips are reshaping tech, and ARM Holdings could ride the wave as a major royalty player. This article explains wh...
A practical guide to understanding finvolution (finv) 2026 earnings, what to watch in the Q1 transcript, and how to p...
As Hillman prepares to share Q1 2026 results, investors want clarity on growth, margins, and cash flow. This practica...
A fresh look at why a trillion-dollar cloud leader could outpace Apple in AI. Learn the mechanics, risks, and how to ...
Nokia’s latest move isn't about handsets—it's about AI-friendly data-center networks. The Nokia acquired Infinera qui...
Investors are eyeing yuanbao (yb) 2026 earnings as the company pivots toward new revenue streams. This guide breaks d...
Chasing Nvidia’s AI-driven rally is tempting, but utility stocks offer stable dividends, growth through grid moderniz...
Baozun's baozun (bzun) 2025 earnings signal shifts in China’s DTC ecosystem. This article breaks down Q4 results, mar...
New IRS data summarized by the Kiplinger Letter shows the ultra-wealthy paid a 23.61% effective federal tax rate in 2...
Two iconic automakers face two different futures. This analysis breaks down why Ford may offer a stronger industrial ...
As Innodata prepares to unveil its Q1 2026 results, investors want clarity on growth drivers, margins, and the path t...